Grant: Discovery Grants Program - Individual
University of Ottawa
$54,000.00
Biofabrication of New Composite Scaffolds for Bone Tissue Engineering Applications
EF 2022-23
Résumé
Recent reviews have highlighted the major potential of electrospun nanofibers for various tissue engineering applications. The proposed research program aims to fabricate new biodegradable composite scaffolds for bone tissue engineering applications using electrospinning technologies and hydrogels. The physical characteristics (composition, architecture, pore size, etc.) of melt electrospun poly(e-caprolactone) (PCL) meshes will first be optimized to promote osteoprogenitor cell attachment and differentiation. Endothelial cells and growth factors, delivered in a controlled manner using fibrin-alginate hydrogels, will then be incorporated into the PCL meshes (previously seeded with osteoprogenitor cells) to promote vascularization. Indeed, a major challenge for bone repair is to provide an environment that promotes not only bone mineralization, but also vascularization. Research will be segmented as follows: Objective 1: Fabricate mineralized poly(e-caprolactone) (PCL) meshes with specific physical characteristics by using melt electrospinning, surface modification, and osteoprogenitor cells. PCL meshes with different pore sizes will be melt electrospun, coated with calcium phosphate (CaP) and characterized by scanning electron microscopy and energy dispersive X-ray spectroscopy. Osteoprogenitor cells will then be cultured on the mesh surface for mineralization.Objective 2: Determine the biological and mechanical properties of the mineralized PCL meshes (developed in Objective 1) combined with fibrin-alginate hydrogels loaded with vascular endothelial growth factor (VEGF)-165 and endothelial cells, under perfused conditions. SEM, quantification of alkaline phosphatase, confocal microscopy, immunocytochemistry, histology/immunohistochemistry, and mechanical testing will be performed to evaluate the biological and mechanical properties of the constructs.The proposed research uses cutting-edge technology to fabricate new mineralized and vascularized bone substitutes. Autologous bone grafts are often used to heal critical-size bone defects, but the use of bone substitutes presents an alternative to this invasive technique. However, current bone substitutes are still facing significant limitations including insufficient supply, high cost and the inability of the substitutes to integrate with the surrounding host tissue. The proposed research will therefore provide tangible benefits to the Canadian health-care system. In addition, it will potentially lead to new and patentable products and/or processes eventually transferable for commercialization. Finally, this research will only be possible by recruiting highly qualified team members, who will be exposed to state-of-the-art technologies and will have a unique opportunity to acquire multidisciplinary training at the interface between fundamental and applied research.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-06826
Name nom
Catelas, Isabelle
Department département
Mechanical Engineering - Génie mécanique
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Biofabrication of New Composite Scaffolds for Bone Tissue Engineering Applications
Application summary
Recent reviews have highlighted the major potential of electrospun nanofibers for various tissue engineering applications. The proposed research program aims to fabricate new biodegradable composite scaffolds for bone tissue engineering applications using electrospinning technologies and hydrogels. The physical characteristics (composition, architecture, pore size, etc.) of melt electrospun poly(e-caprolactone) (PCL) meshes will first be optimized to promote osteoprogenitor cell attachment and differentiation. Endothelial cells and growth factors, delivered in a controlled manner using fibrin-alginate hydrogels, will then be incorporated into the PCL meshes (previously seeded with osteoprogenitor cells) to promote vascularization. Indeed, a major challenge for bone repair is to provide an environment that promotes not only bone mineralization, but also vascularization. Research will be segmented as follows: Objective 1: Fabricate mineralized poly(e-caprolactone) (PCL) meshes with specific physical characteristics by using melt electrospinning, surface modification, and osteoprogenitor cells. PCL meshes with different pore sizes will be melt electrospun, coated with calcium phosphate (CaP) and characterized by scanning electron microscopy and energy dispersive X-ray spectroscopy. Osteoprogenitor cells will then be cultured on the mesh surface for mineralization.Objective 2: Determine the biological and mechanical properties of the mineralized PCL meshes (developed in Objective 1) combined with fibrin-alginate hydrogels loaded with vascular endothelial growth factor (VEGF)-165 and endothelial cells, under perfused conditions. SEM, quantification of alkaline phosphatase, confocal microscopy, immunocytochemistry, histology/immunohistochemistry, and mechanical testing will be performed to evaluate the biological and mechanical properties of the constructs.The proposed research uses cutting-edge technology to fabricate new mineralized and vascularized bone substitutes. Autologous bone grafts are often used to heal critical-size bone defects, but the use of bone substitutes presents an alternative to this invasive technique. However, current bone substitutes are still facing significant limitations including insufficient supply, high cost and the inability of the substitutes to integrate with the surrounding host tissue. The proposed research will therefore provide tangible benefits to the Canadian health-care system. In addition, it will potentially lead to new and patentable products and/or processes eventually transferable for commercialization. Finally, this research will only be possible by recruiting highly qualified team members, who will be exposed to state-of-the-art technologies and will have a unique opportunity to acquire multidisciplinary training at the interface between fundamental and applied research.